Oral capecitabine preferred in CRC

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1529, 2006-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Capacity of capecitabine in CRC highlighted by 5-year results

By  

Inpharma, Vol. 1, Iss. 1609, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Capecitabine: effective oral fluoropyrimidine chemotherapy

By McKendrick Joseph   Coutsouvelis John  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1231-1239

Informa Healthcare

Access to resources Recommend Favorite

Capecitabine: fulfilling the promise of oral chemotherapy

By Marshall John L   Hwang Jimmy J  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. : 733-743

Informa Healthcare

Access to resources Recommend Favorite

Capecitabine

By Dooley M.   Goa K.L.  

Drugs, Vol. 58, Iss. 1, 1999-07 ,pp. : 69-76

Adis International

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies

By Deenen Maarten  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1557-1565

Springer Publishing Company

Access to resources Recommend Favorite